Table 7.
Whole blood (A), renal function (B), biochemical results (C) and hepatic function (D) of the patients who took BCc1 nanomedicine revealed that none of the patients suffered deficiency
| Index | Unit | Amount |
|---|---|---|
| (A) Whole blood function | ||
| WBC | ×1000/mm3 | 5.1 ± 1.3 |
| RBC | Mill/mm3 | 4.4 ± 0.6 |
| HGB | g/dl | 12.5 ± 1.8 |
| HCT | % | 40.1 ± 4.5 |
| MCV | Fl | 88.4 ± 10.2 |
| MCH | pg | 28.8 ± 4.3 |
| MCHC | g/dl | 32.9 ± 1.8 |
| Platelet | ×1000/mm3 | 195 ± 27 |
| RDW | 43 ± 21.1 | |
| PDW | Fl | 13.3 ± 0.8 |
| MPV | Fl | 10 ± 1.6 |
| (B) Renal function | ||
| Urea | mg/dl | 30.4 ± 13.6 |
| Creatinine | mg/dl | 1.0 ± 0.1 |
| (C) Biochemical function | ||
| Iron | µg/dl | 56 ± 15 |
| TIBC | µg/dl | 314 ± 30 |
| UIBC | µg/dl | 258 ± 10 |
| Ferritin | ng/dl | 250 ± 80 |
| Sodium | mmol/l | 139 ± 7 |
| Potassium | mmol/l | 4.1 ± 0.7 |
| Chloride | mmol/l | 105 ± 10 |
| (D) Hepatic function | ||
| Triglycerides | mg/dl | 102 ± 48 |
| Total cholesterol | mg/dl | 183 ± 22 |
| AST (SGOT) | U/l | 19.1 ± 5.1 |
| ALT (SGPT) | U/l | 14.3 ± 4.3 |
| Alkaline phosphatase | IU/l | 286.6 ± 95 |
| Bilirubin (total) | mg/dl | 0.725 ± 0.09 |
| Bilirubin (direct) | mg/dl | 0.2 ± 0.1 |